Orthofix Medical, a global medical device company with a spine and orthopaedics focus, has launched their fiberFUSE Strip and seen the first patient implants with the product, an advanced demineralized fibre bone-graft solution containing cancellous bone.
The fiberFUSE Strip is formulated as a convenient preformed bone-graft strip to enable optimized application for posterior cervical, posterior lumbar and degenerative spinal procedures.
Comprised of natural bone, the fiberFUSE Strip contains a unique mixture of mineralized cancellous and demineralized cortical bone, with no carrier added, to create a natural scaffold allowing for re-vascularization, cellular ingrowth and new bone formation.
“We are pleased to introduce this next- generation formulation in the fiberFUSE allograft line,” said Kevin Kenny, President of Orthofix Global Spine. “The fiberFUSE Strip delivers a high-quality advanced bone-graft option in a convenient, easy-to-use strip preparation. This technology advancement was developed as part of our strategy to provide procedurally-focused solutions for spine surgeons and their patients.”
MTF Biologics is the exclusive processor of the Orthofix fiberFUSE Strip. Their proprietary, validated aseptic processing methods retain the natural growth factors within the cortical fibres. The fibres inter-connect, resulting in a pliable, cohesive
graft. The cancellous matrix component provides a porous scaffold to allow in-growth of host vasculature, osteoblasts and mesenchymal stem cells. The fiberFUSE Strip can be rapidly rehydrated with the surgeon’s reconstitution solution of choice.
- For more information, visit: www.orthofix.com/ifus/fiberfusestrip/
